Dusa Pharmaceuticals, Inc.

Intrinsic Therapeutics, Inc.

Takeda Pharmaceutical Company Limited

Sun Pharmaceutical Industries Limited

Thomas Boyajian

Mark Carota

Brian Mazejka

Gregory Lambrecht

Robert Kevin Moore

Jacob Einhorn

Sean M Kavanaugh

Christopher J Tarapata

Almir Velagic

Amey Mathakari

Joseph M Giamo

Anh Nguyen

Chris Tarapata

Michael Leccese

Dhairya Kiritkumar Mehta

Kevin R Moore

R Kevin Moore

Medicament access device

An adjustable illuminator for photodynamically diagnosing or treating a surface includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a 'lighted hinge' to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.

Adjustable illuminator for photodynamic therapy and diagnosis

An illuminator for photodynamically diagnosing or treating a surface includes a plurality of panels. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of panels. The plurality of light sources are configured to irradiate the surface with substantially uniform intensity visible light. The illuminator also includes a heat source configured to emit heat to a patient. The heat increases the generation of a photoactivatable agent and thus shortens the time needed to complete photodynamic therapy.

Adjustable illuminators and methods for photodynamic therapy and diagnosis

An applicator for dispensing a solution having two or more components includes a hollow body having a head provided at one end of the hollow body for dispersion of the solution and a breaking mechanism attached to the hollow body. The breaking mechanism includes at least one projection extendable into an interior of the hollow body. The applicator further includes a plurality of ampoules placed in the interior of the hollow body. The plurality of ampoules contains the two or more components. Upon activation of the breaking mechanism, the at least one projection applies a force to the plurality of ampoules such that the plurality of ampoules break and release the two or more components to form the solution.

Method and apparatus for applying a topical solution

In some embodiments, a reconstitution or medicinal fluid delivery device includes a transfer engine including two fluidly connected spikes, each configured to pierce a container. A check valve may be disposed between the two spikes to allow unidirectional flow from one container to the other. Physical access to a fluid outlet may be obstructed by a housing until the reconstitution or medicinal fluid delivery device is actuated, whereupon physical access to the fluid outlet is permitted. The reconstitution or medicinal fluid delivery device may be placed on a flat surface and actuated with force applied in a single direction toward the flat surface.

Medicinal fluid delivery device

A method of administering 5-aminolevulinic acid (ALA) to a patient uses an adjustable illuminator for photodynamically diagnosing or treating a surface and which includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a 'lighted hinge' to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.

Method of administering 5-aminolevulinic acid (ALA) to a patient

Embodiments relate generally to tissue anchors and methods of delivering same to the intervertebral disc or other sites within the body. In some embodiments, the anchors provide increased pull-out resistance, stability and/or contact with tissue involving a reduced amount of penetration. In some embodiments, delivery methods are minimally invasive and can include linear, lateral, and off-angle implantation or driving of anchors along, against or within tissue surfaces. Several embodiments disclose anchors and anchoring systems that effectively reconstruct or augment vertebral endplate surfaces.

Method for vertebral endplate reconstruction

Embodiments of the invention relate generally to tissue anchors and methods of delivering same to the intervertebral disc or other sites within the body. In some embodiments, the anchors provide pull-out resistance, stability and/or maximize contact with tissue involving a minimum amount of penetration. In some embodiments, delivery methods are minimally invasive and include linear, lateral, and off-angle implantation or driving of anchors along, against or within tissue surfaces.

Vertebral anchoring methods

Anchoring system for disc repair

Growing community of inventors

Wilmington, MA, United States of America

Thomas Boyajian